Alcidion Group Ltd
ASX:ALC
Alcidion Group Ltd
ASX:ALC
Price:
0.055 AUD
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
The Relative Value of one
ALC
stock under the Base Case scenario is
0.143
AUD.
Compared to the current market price of 0.055 AUD,
Alcidion Group Ltd
is
Undervalued by 62%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALC
Relative Value
Base Case
0.143
AUD
Undervaluation 62%
Valuation Multiples
Multiples Across Competitors
ALC Competitors Multiples
Alcidion Group Ltd Competitors
Alcidion Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Alcidion Group Ltd
ASX:ALC
|
73.8m AUD | 1.8 | -14.4 | -10.3 | -10.3 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 13.7 | 61.6 | 61.4 | 66.1 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | 27.5 | 14.6 | 16.4 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.7B AUD | 78.1 | 163.9 | 112.7 | 112.7 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 11.2 | -331.8 | -175.3 | -162.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.5 | 32.2 | 21.5 | 22.9 | |
| SE |
|
Sectra AB
STO:SECT B
|
42B SEK | 25.7 | 99.1 | -66.2 | -66.2 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -22.1 | 26.1 | 277.7 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 | -319.5 | 34.1 | -111.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
